Here is a link to the latest research presented on Thursday night at the Australian Gastroenterology Week. It was presented by a team lead by Professor Jacob George who is the head of the Liver Department at Westmead Hospital/Millenium Institute.
Title of presentation was: SERUM DICKKOPF-1, OSTEOPONTIN AND MIDKINE AS NOVEL BIOMARKERS FOR THE DIAGNOSIS AND PRE-CLINICAL DIAGNOSIS OF HEPATOCELLULAR CARCINOMA.
Www.agw.org.au
The feedback was that Midkine was a very accurate predictor of early liver cancer. This just just backs up research done early in the year in France and some research last year in China.
- Forums
- ASX - By Stock
- Midkine as early liver cancer biomarker
Here is a link to the latest research presented on Thursday...
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AN1 (ASX) Chart |
Day chart unavailable
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online